Cargando…

Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant

N-acetyltransferase 1 (NAT1) is a xenobiotic metabolizing enzyme that uses acetyl coenzyme A (AcCoA) as a cofactor for N-acetylation of many carcinogens including aromatic amines and alkylanilines. NAT1 is characterized by single nucleotide polymorphisms (SNPs) that may modulate affinity towards AcC...

Descripción completa

Detalles Bibliográficos
Autores principales: Habil, Mariam R., Doll, Mark A., Hein, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650386/
https://www.ncbi.nlm.nih.gov/pubmed/36386142
http://dx.doi.org/10.3389/fphar.2022.931323
_version_ 1784828005530468352
author Habil, Mariam R.
Doll, Mark A.
Hein, David W.
author_facet Habil, Mariam R.
Doll, Mark A.
Hein, David W.
author_sort Habil, Mariam R.
collection PubMed
description N-acetyltransferase 1 (NAT1) is a xenobiotic metabolizing enzyme that uses acetyl coenzyme A (AcCoA) as a cofactor for N-acetylation of many carcinogens including aromatic amines and alkylanilines. NAT1 is characterized by single nucleotide polymorphisms (SNPs) that may modulate affinity towards AcCoA. In the current study, we used Chinese hamster ovary (CHO) cells stably transfected with human NAT1*4 (reference allele) or NAT1*14B (variant allele) to measure AcCoA kinetic parameters for N-acetyltransferase activity measurements towards p-aminobenzoic acid (PABA), 4-aminobiphenyl (4-ABP), β-naphthylamine (BNA), benzidine and 3,4-dimethylaniline (3,4-DMA). Our results showed higher N-acetylation rates for each substrate catalyzed by NAT1*4 compared to NAT1*14B. NAT1*4 exhibited higher affinity to AcCoA when catalyzing the N-acetylation of BNA and benzidine compared to NAT1*14B. The results of the current study provide further insights into differences in carcinogen metabolism among individuals possessing the NAT1*14B haplotype.
format Online
Article
Text
id pubmed-9650386
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96503862022-11-15 Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant Habil, Mariam R. Doll, Mark A. Hein, David W. Front Pharmacol Pharmacology N-acetyltransferase 1 (NAT1) is a xenobiotic metabolizing enzyme that uses acetyl coenzyme A (AcCoA) as a cofactor for N-acetylation of many carcinogens including aromatic amines and alkylanilines. NAT1 is characterized by single nucleotide polymorphisms (SNPs) that may modulate affinity towards AcCoA. In the current study, we used Chinese hamster ovary (CHO) cells stably transfected with human NAT1*4 (reference allele) or NAT1*14B (variant allele) to measure AcCoA kinetic parameters for N-acetyltransferase activity measurements towards p-aminobenzoic acid (PABA), 4-aminobiphenyl (4-ABP), β-naphthylamine (BNA), benzidine and 3,4-dimethylaniline (3,4-DMA). Our results showed higher N-acetylation rates for each substrate catalyzed by NAT1*4 compared to NAT1*14B. NAT1*4 exhibited higher affinity to AcCoA when catalyzing the N-acetylation of BNA and benzidine compared to NAT1*14B. The results of the current study provide further insights into differences in carcinogen metabolism among individuals possessing the NAT1*14B haplotype. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9650386/ /pubmed/36386142 http://dx.doi.org/10.3389/fphar.2022.931323 Text en Copyright © 2022 Habil, Doll and Hein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Habil, Mariam R.
Doll, Mark A.
Hein, David W.
Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title_full Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title_fullStr Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title_full_unstemmed Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title_short Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
title_sort acetyl coenzyme a kinetic studies on n-acetylation of environmental carcinogens by human n-acetyltransferase 1 and its nat1*14b variant
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650386/
https://www.ncbi.nlm.nih.gov/pubmed/36386142
http://dx.doi.org/10.3389/fphar.2022.931323
work_keys_str_mv AT habilmariamr acetylcoenzymeakineticstudiesonnacetylationofenvironmentalcarcinogensbyhumannacetyltransferase1anditsnat114bvariant
AT dollmarka acetylcoenzymeakineticstudiesonnacetylationofenvironmentalcarcinogensbyhumannacetyltransferase1anditsnat114bvariant
AT heindavidw acetylcoenzymeakineticstudiesonnacetylationofenvironmentalcarcinogensbyhumannacetyltransferase1anditsnat114bvariant